Remove 2023 Remove Invention Remove Patent Application Remove Patent Law
article thumbnail

Patent Application for Gilead’s Lenacapavir Opposed: Saving Generics of HIV Drugs?

SpicyIP

The looming threat is the pending patent applications by Gilead in India. A Look at the Pre-Grant Oppositions Gilead has multiple patent applications for Lenacapavir in India, including those seeking patents on its choline and sodium salts. and the oppositions raised against these applications.

article thumbnail

CALL FOR TRYOUTS – USPTO National Patent Application Drafting Competition

IPilogue

2021-2022 was a big year for the Osgoode’s mooting team entry for the USPTO National Patent Application Drafting Competition. We invite you to participate in the tryouts for the 2022-2023 National Patent Application Drafting Competition ! About the National Patent Application Drafting Competition.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Era of China Patent Law

LexBlog IP

This change represents a considerable shift in the intellectual property law landscape within the country, aiming to promote an environment of genuine innovation and integrity. Genuine Inventive Activities: Requires applications to be based on real and original inventive activities.

article thumbnail

Thaler v. Comptroller-General: Supreme Court Affirms that an AI Cannot be an Inventor under UK Patent Law

Intepat

Thaler, the applicant, approached the UK Patent Office with two patent applications. At the heart of this case lies a critical examination of the UK Patent Act 1977, specifically Section 13(2). Failing to comply would result in the application being considered withdrawn.

article thumbnail

Shaping the Future of Patent Law: The Amgen v. Sanofi Decision and Bite-Sized Monopolies

Patently-O

The Court held that Amgen’s patent claims were invalid due to a lack of enablement, as they failed to provide adequate guidance for making and using the claimed antibodies. — (2023) ( 21-757_k5g1 ). In other words, the specification must enable the full scope of the invention as defined by its claims.

article thumbnail

When is the inventor of an AI model also an inventor of the model's output? A closer look at the USPTO Guidance for AI-Assisted Inventions

The IPKat

According to the USPTO guidance for AI-assisted inventions , AI has the potential to solve some of society's most difficult challenges. However, in the patent realm, the USPTO also believes that "inventorship analysis should focus on human contributions, as patents function to incentivize and reward human ingenuity".

article thumbnail

The Federal Circuit hints at Enablement requirements for Artificial Intelligence (AI) Inventions

LexBlog IP

However, in a recent case, the Federal Circuit found that a “machine learning” claim element lacked sufficient enablement because both the claim itself and the written description of the patent to which it belonged failed to describe “ how ” the claimed invention implemented this element. § 112(a)).